Baxter International BAX
NYSE BAX
$26.34 -0.07 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018)

Baxter International (BAX) posted quarterly Non-Current Deferred Tax Liability of $205.0 million for Q4 2018, down 26.79% year-over-year from $280.0 million in Q4 2017, and down 26.79% quarter-over-quarter from $280.0 million in Q4 2017.

Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018) Analysis & Trends

Baxter International (BAX) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $205.0 million the latest figure, recorded in Q4 2018.

  • In Q4 2018, Non-Current Deferred Tax Liability fell 26.79% year-over-year to $205.0 million; the TTM figure through Dec 2018 stood at $205.0 million (down 26.79% YoY), while the FY2018 annual figure was $205.0 million, down 26.79% from the prior year.
  • Non-Current Deferred Tax Liability fell to $205.0 million in Q4 2018 per BAX's latest filing, from $280.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $280.0 million in Q4 2017 and bottomed at $52.0 million in Q1 2015.
  • Historically, Non-Current Deferred Tax Liability has averaged $165.5 million across 5 years, with a median of $181.5 million in 2014.
  • Annual changes were most pronounced in 2016 — Non-Current Deferred Tax Liability slumped 52.31% — and 2017, when it jumped 201.08%.
  • Baxter International's Non-Current Deferred Tax Liability stood at $168.0 million in 2014, then increased by 16.07% to $195.0 million in 2015, then tumbled by 52.31% to $93.0 million in 2016, then surged by 201.08% to $280.0 million in 2017, then declined by 26.79% to $205.0 million in 2018.
  • Business Quant data shows BAX's Non-Current Deferred Tax Liability at $205.0 million in Q4 2018, $280.0 million in Q4 2017, and $93.0 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2018 205.00 Mn
Dec 31, 2018 205.00 Mn
Dec 31, 2017 280.00 Mn
Dec 31, 2017 280.00 Mn
Dec 31, 2016 93.00 Mn
Dec 31, 2016 93.00 Mn
Dec 31, 2015 195.00 Mn
Dec 31, 2015 195.00 Mn
Mar 31, 2015 52.00 Mn
Mar 31, 2015 52.00 Mn
Dec 31, 2014 168.00 Mn
Dec 31, 2014 168.00 Mn